Selected research
Market Analysis & Forecast
Global Advance Directives Software Market Analysis and Forecast 2026-2032
Market perspective
The global Advance Directives Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Advance Directives Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Advance Directives Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Advance Directives Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Advance Directives Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Advance Directives Software include Island Health, Honor My Decisions, WiserCare Inc., ADvault, Inc., VyncaCare, Iris Healthcare, Bronson Health Care Group, Inc., Koda Health and New Century Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Advance Directives Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Advance Directives Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Advance Directives Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Advance Directives Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Advance Directives Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Advance Directives Software revenue, projected growth trends, production technology, application and end-user industry.
Advance Directives Software Segment by Company
Island Health
Honor My Decisions
WiserCare Inc.
ADvault, Inc.
VyncaCare
Iris Healthcare
Bronson Health Care Group, Inc.
Koda Health
New Century Health
Thanacare
ThroughCare, Inc.
Vital Decisions
Affirm Health Inc.
MIDEO
Sharp HealthCare
ACP Decisions
Advance Directives Software Segment by Type
Document Preparation Software
Electronic Health Record (EHR) Integration
Online Platforms and Portals
Comprehensive Healthcare Planning Software
Advance Directives Software Segment by Application
Healthcare
Other
Advance Directives Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advance Directives Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Advance Directives Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advance Directives Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Advance Directives Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Advance Directives Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Advance Directives Software revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Document Preparation Software
- Electronic Health Record (EHR) Integration
- Online Platforms and Portals
- Comprehensive Healthcare Planning Software
Applications
- Healthcare
- Other
Companies covered
- Island Health
- Honor My Decisions
- WiserCare Inc.
- ADvault, Inc.
- VyncaCare
- Iris Healthcare
- Bronson Health Care Group, Inc.
- Koda Health
- New Century Health
- Thanacare
- ThroughCare, Inc.
- Vital Decisions
- Affirm Health Inc.
- MIDEO
- Sharp HealthCare
- ACP Decisions
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Advance Directives Software Market by Type
- 1.2.1 Global Advance Directives Software Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Document Preparation Software
- 1.2.3 Electronic Health Record (EHR) Integration
- 1.2.4 Online Platforms and Portals
- 1.2.5 Comprehensive Healthcare Planning Software
- 1.3 Advance Directives Software Market by Application
- 1.3.1 Global Advance Directives Software Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Healthcare
- 1.3.3 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Advance Directives Software Market Dynamics
- 2.1 Advance Directives Software Industry Trends
- 2.2 Advance Directives Software Industry Drivers
- 2.3 Advance Directives Software Industry Opportunities and Challenges
- 2.4 Advance Directives Software Industry Restraints
3 Global Growth Perspective
- 3.1 Global Advance Directives Software Market Perspective (2021-2032)
- 3.2 Global Advance Directives Software Growth Trends by Region
- 3.2.1 Global Advance Directives Software Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Advance Directives Software Market Size by Region (2021-2026)
- 3.2.3 Global Advance Directives Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Advance Directives Software Revenue by Players
- 4.1.1 Global Advance Directives Software Revenue by Players (2021-2026)
- 4.1.2 Global Advance Directives Software Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Advance Directives Software Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Advance Directives Software Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Advance Directives Software Key Players Headquarters & Area Served
- 4.4 Global Advance Directives Software Players, Product Type & Application
- 4.5 Global Advance Directives Software Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Advance Directives Software Market CR5 and HHI
- 4.6.3 2025 Advance Directives Software Tier 1, Tier 2, and Tier 3
5 Advance Directives Software Market Size by Type
- 5.1 Global Advance Directives Software Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Advance Directives Software Revenue by Type (2021-2032)
- 5.3 Global Advance Directives Software Revenue Market Share by Type (2021-2032)
6 Advance Directives Software Market Size by Application
- 6.1 Global Advance Directives Software Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Advance Directives Software Revenue by Application (2021-2032)
- 6.3 Global Advance Directives Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Island Health
- 7.1.1 Island Health Company Information
- 7.1.2 Island Health Business Overview
- 7.1.3 Island Health Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.1.4 Island Health Advance Directives Software Product Portfolio
- 7.1.5 Island Health Recent Developments
- 7.2 Honor My Decisions
- 7.2.1 Honor My Decisions Company Information
- 7.2.2 Honor My Decisions Business Overview
- 7.2.3 Honor My Decisions Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.2.4 Honor My Decisions Advance Directives Software Product Portfolio
- 7.2.5 Honor My Decisions Recent Developments
- 7.3 WiserCare Inc.
- 7.3.1 WiserCare Inc. Company Information
- 7.3.2 WiserCare Inc. Business Overview
- 7.3.3 WiserCare Inc. Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.3.4 WiserCare Inc. Advance Directives Software Product Portfolio
- 7.3.5 WiserCare Inc. Recent Developments
- 7.4 ADvault, Inc.
- 7.4.1 ADvault, Inc. Company Information
- 7.4.2 ADvault, Inc. Business Overview
- 7.4.3 ADvault, Inc. Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.4.4 ADvault, Inc. Advance Directives Software Product Portfolio
- 7.4.5 ADvault, Inc. Recent Developments
- 7.5 VyncaCare
- 7.5.1 VyncaCare Company Information
- 7.5.2 VyncaCare Business Overview
- 7.5.3 VyncaCare Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.5.4 VyncaCare Advance Directives Software Product Portfolio
- 7.5.5 VyncaCare Recent Developments
- 7.6 Iris Healthcare
- 7.6.1 Iris Healthcare Company Information
- 7.6.2 Iris Healthcare Business Overview
- 7.6.3 Iris Healthcare Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.6.4 Iris Healthcare Advance Directives Software Product Portfolio
- 7.6.5 Iris Healthcare Recent Developments
- 7.7 Bronson Health Care Group, Inc.
- 7.7.1 Bronson Health Care Group, Inc. Company Information
- 7.7.2 Bronson Health Care Group, Inc. Business Overview
- 7.7.3 Bronson Health Care Group, Inc. Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.7.4 Bronson Health Care Group, Inc. Advance Directives Software Product Portfolio
- 7.7.5 Bronson Health Care Group, Inc. Recent Developments
- 7.8 Koda Health
- 7.8.1 Koda Health Company Information
- 7.8.2 Koda Health Business Overview
- 7.8.3 Koda Health Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.8.4 Koda Health Advance Directives Software Product Portfolio
- 7.8.5 Koda Health Recent Developments
- 7.9 New Century Health
- 7.9.1 New Century Health Company Information
- 7.9.2 New Century Health Business Overview
- 7.9.3 New Century Health Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.9.4 New Century Health Advance Directives Software Product Portfolio
- 7.9.5 New Century Health Recent Developments
- 7.10 Thanacare
- 7.10.1 Thanacare Company Information
- 7.10.2 Thanacare Business Overview
- 7.10.3 Thanacare Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.10.4 Thanacare Advance Directives Software Product Portfolio
- 7.10.5 Thanacare Recent Developments
- 7.11 ThroughCare, Inc.
- 7.11.1 ThroughCare, Inc. Company Information
- 7.11.2 ThroughCare, Inc. Business Overview
- 7.11.3 ThroughCare, Inc. Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.11.4 ThroughCare, Inc. Advance Directives Software Product Portfolio
- 7.11.5 ThroughCare, Inc. Recent Developments
- 7.12 Vital Decisions
- 7.12.1 Vital Decisions Company Information
- 7.12.2 Vital Decisions Business Overview
- 7.12.3 Vital Decisions Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.12.4 Vital Decisions Advance Directives Software Product Portfolio
- 7.12.5 Vital Decisions Recent Developments
- 7.13 Affirm Health Inc.
- 7.13.1 Affirm Health Inc. Company Information
- 7.13.2 Affirm Health Inc. Business Overview
- 7.13.3 Affirm Health Inc. Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.13.4 Affirm Health Inc. Advance Directives Software Product Portfolio
- 7.13.5 Affirm Health Inc. Recent Developments
- 7.14 MIDEO
- 7.14.1 MIDEO Company Information
- 7.14.2 MIDEO Business Overview
- 7.14.3 MIDEO Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.14.4 MIDEO Advance Directives Software Product Portfolio
- 7.14.5 MIDEO Recent Developments
- 7.15 Sharp HealthCare
- 7.15.1 Sharp HealthCare Company Information
- 7.15.2 Sharp HealthCare Business Overview
- 7.15.3 Sharp HealthCare Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.15.4 Sharp HealthCare Advance Directives Software Product Portfolio
- 7.15.5 Sharp HealthCare Recent Developments
- 7.16 ACP Decisions
- 7.16.1 ACP Decisions Company Information
- 7.16.2 ACP Decisions Business Overview
- 7.16.3 ACP Decisions Advance Directives Software Revenue and Gross Margin (2021-2026)
- 7.16.4 ACP Decisions Advance Directives Software Product Portfolio
- 7.16.5 ACP Decisions Recent Developments
8 North America
- 8.1 North America Advance Directives Software Revenue (2021-2032)
- 8.2 North America Advance Directives Software Revenue by Type (2021-2032)
- 8.2.1 North America Advance Directives Software Revenue by Type (2021-2026)
- 8.2.2 North America Advance Directives Software Revenue by Type (2027-2032)
- 8.3 North America Advance Directives Software Revenue Share by Type (2021-2032)
- 8.4 North America Advance Directives Software Revenue by Application (2021-2032)
- 8.4.1 North America Advance Directives Software Revenue by Application (2021-2026)
- 8.4.2 North America Advance Directives Software Revenue by Application (2027-2032)
- 8.5 North America Advance Directives Software Revenue Share by Application (2021-2032)
- 8.6 North America Advance Directives Software Revenue by Country
- 8.6.1 North America Advance Directives Software Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Advance Directives Software Revenue by Country (2021-2026)
- 8.6.3 North America Advance Directives Software Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Advance Directives Software Revenue (2021-2032)
- 9.2 Europe Advance Directives Software Revenue by Type (2021-2032)
- 9.2.1 Europe Advance Directives Software Revenue by Type (2021-2026)
- 9.2.2 Europe Advance Directives Software Revenue by Type (2027-2032)
- 9.3 Europe Advance Directives Software Revenue Share by Type (2021-2032)
- 9.4 Europe Advance Directives Software Revenue by Application (2021-2032)
- 9.4.1 Europe Advance Directives Software Revenue by Application (2021-2026)
- 9.4.2 Europe Advance Directives Software Revenue by Application (2027-2032)
- 9.5 Europe Advance Directives Software Revenue Share by Application (2021-2032)
- 9.6 Europe Advance Directives Software Revenue by Country
- 9.6.1 Europe Advance Directives Software Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Advance Directives Software Revenue by Country (2021-2026)
- 9.6.3 Europe Advance Directives Software Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Advance Directives Software Revenue (2021-2032)
- 10.2 China Advance Directives Software Revenue by Type (2021-2032)
- 10.2.1 China Advance Directives Software Revenue by Type (2021-2026)
- 10.2.2 China Advance Directives Software Revenue by Type (2027-2032)
- 10.3 China Advance Directives Software Revenue Share by Type (2021-2032)
- 10.4 China Advance Directives Software Revenue by Application (2021-2032)
- 10.4.1 China Advance Directives Software Revenue by Application (2021-2026)
- 10.4.2 China Advance Directives Software Revenue by Application (2027-2032)
- 10.5 China Advance Directives Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Advance Directives Software Revenue (2021-2032)
- 11.2 Asia Advance Directives Software Revenue by Type (2021-2032)
- 11.2.1 Asia Advance Directives Software Revenue by Type (2021-2026)
- 11.2.2 Asia Advance Directives Software Revenue by Type (2027-2032)
- 11.3 Asia Advance Directives Software Revenue Share by Type (2021-2032)
- 11.4 Asia Advance Directives Software Revenue by Application (2021-2032)
- 11.4.1 Asia Advance Directives Software Revenue by Application (2021-2026)
- 11.4.2 Asia Advance Directives Software Revenue by Application (2027-2032)
- 11.5 Asia Advance Directives Software Revenue Share by Application (2021-2032)
- 11.6 Asia Advance Directives Software Revenue by Country
- 11.6.1 Asia Advance Directives Software Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Advance Directives Software Revenue by Country (2021-2026)
- 11.6.3 Asia Advance Directives Software Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Advance Directives Software Revenue (2021-2032)
- 12.2 SAMEA Advance Directives Software Revenue by Type (2021-2032)
- 12.2.1 SAMEA Advance Directives Software Revenue by Type (2021-2026)
- 12.2.2 SAMEA Advance Directives Software Revenue by Type (2027-2032)
- 12.3 SAMEA Advance Directives Software Revenue Share by Type (2021-2032)
- 12.4 SAMEA Advance Directives Software Revenue by Application (2021-2032)
- 12.4.1 SAMEA Advance Directives Software Revenue by Application (2021-2026)
- 12.4.2 SAMEA Advance Directives Software Revenue by Application (2027-2032)
- 12.5 SAMEA Advance Directives Software Revenue Share by Application (2021-2032)
- 12.6 SAMEA Advance Directives Software Revenue by Country
- 12.6.1 SAMEA Advance Directives Software Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Advance Directives Software Revenue by Country (2021-2026)
- 12.6.3 SAMEA Advance Directives Software Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst